Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-01
2009-06-02
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S189000
Reexamination Certificate
active
07541373
ABSTRACT:
This invention relates to aryl carbonyl derivatives which are activators of glucokinase which may be useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial.
REFERENCES:
patent: 3152136 (1964-10-01), Harris et al.
patent: 3317534 (1967-05-01), Nitta et al.
patent: 7196104 (2007-03-01), Askew et al.
patent: 2117807 (1971-10-01), None
patent: 2712630 (1978-09-01), None
patent: 1211246 (2002-06-01), None
patent: WO 97/24328 (1997-07-01), None
patent: WO 99/24035 (1999-05-01), None
patent: WO 99/32106 (1999-07-01), None
patent: WO 99/32111 (1999-07-01), None
patent: WO 00/58293 (2000-10-01), None
patent: WO 00/58293 (2000-10-01), None
patent: WO 01/00206 (2001-04-01), None
patent: WO 01/44216 (2001-06-01), None
patent: WO 01/57008 (2001-08-01), None
patent: WO 01/83465 (2001-11-01), None
patent: WO 01/83478 (2001-11-01), None
patent: WO 01/83478 (2001-11-01), None
patent: WO 01/85706 (2001-11-01), None
patent: WO 01/85707 (2001-11-01), None
patent: WO 02/08209 (2002-01-01), None
patent: WO 02/14311 (2002-02-01), None
patent: WO 02/14311 (2002-02-01), None
patent: WO 02/46173 (2002-06-01), None
patent: WO 02/070494 (2002-09-01), None
patent: WO 03/055482 (2003-07-01), None
patent: WO 03/007027 (2003-08-01), None
Atwal et al., Journal of Medicinal Chemistry, vol. 39, No. 1, pp. 304-313.
Hirsch et al., NIH, Annals of Internal Medicine, vol. 103, pp. 147-151 (1985).
Mann, The New England Journal of Medicine, vol. 291, pp. 226-232 (1974).
Purchase et al., Bioorganic and Medicinal Chemistry Letters, vol. 6, No. 15, pp. 1753-1758 (1996).
Regel et al., Liebigs Annalen der Chemie, vol. 1, pp. 145-158 (1977).
White et al., Journal of Medicinal Chemistry, vol. 39, No. 22, pp. 4382-4395 (1996).
Andrews Robert Carl
Ankersen Michael
Bloch Paw
Guzel Mustafa
Jeppesen Lone
Coppins Janet L
Novo Nordisk A S
Saeed Kamal
Wilk-Orescan Rosemarie R.
LandOfFree
Aryl carbonyl derivatives as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl carbonyl derivatives as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl carbonyl derivatives as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4116859